Search Results 1311-1320 of 15739 for Reabsorption
Mayo Clinic researchers found a potential way to improve access for patients with end-stage kidney disease to hemodialysis. Latest stories.
The purpose of this study is to compare loco-regional liposomal bupivacaine injection versus normal saline (placebo control group) to assess possible reduction ...
In a bold move blending pioneering technology with medical science, Mayo Clinic's Center for Individualized Medicine is forging a new frontier in healthcare ...
The purpose of this study is to understand the differential response of lipolysis in obesity to interventions that should stimulate lipolysis and intracellular ...
Mayo Clinic physicians share how whole blood use has waxed and waned in trauma care, currently becoming more common. They discuss advantages, history, ...
Mayo scientists researching 'beyond DNA' to advance personalized medicine featured image · Research · Mayo Clinic Laboratories uses enhanced technology to ...
Studies confirm that ultrasound-guided thyroid nodule radiofrequency ablation (RFA) is a safe, effective outpatient treatment for patients with symptomatic ...
The needs of patients are at the forefront of healthcare transformation through artificial intelligence (AI). This was the overarching theme at Mayo Clinic's AI ...
Marla Broadfoot, Ph.D. November 22, 2025. Landmark Mayo Clinic study finds stenting reduces stroke risk in people with carotid artery ...
Medicines are needed after an organ transplant to prevent organ rejection. Learn more about the different medicines and their side effects.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.